The osmotic resistance of the erythrocytes can be used as a sensitive marker for the detection of the early stages of hyperglycemia (prediabetes). This set of clinical trials will make it possible to identify diseases that make up the triad at an early stage. Early detection of disorders and continued research in this direction will help in the development of a diagnostic scheme for the prevention of such patients. Based on our data, research into anti-oxidation drugs is very important. With the help of the array of studies described in the article and antioxidant treatment, the likelihood of successful treatment will increase.
Keyphrases
- early stage
- clinical trial
- newly diagnosed
- ejection fraction
- oxidative stress
- high resolution
- hydrogen peroxide
- squamous cell carcinoma
- randomized controlled trial
- diabetic rats
- patient reported outcomes
- nitric oxide
- artificial intelligence
- rectal cancer
- drug induced
- quantum dots
- sensitive detection
- case control
- locally advanced
- replacement therapy